Multitarget Stool DNA Tests More Costly Than FIT for Colorectal Cancer Detection

Medically reviewed by Carmen Pope, BPharm. Last updated on May 15, 2025.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, May 14, 2025 -- Multitarget stool DNA test (MSDT)- and next-generation MSDT (N-G MSDT)-based screening have higher costs per detected advanced neoplasia case or early colorectal cancer (CRC) case than fecal immunochemical tests (FITs), according to a research letter published online May 13 in the Annals of Internal Medicine.

Noting that MSDTs have higher sensitivity than FITs and are increasingly used for CRC screening, Hermann Brenner, M.D., M.P.H., from the German Cancer Research Center in Heidelberg, and colleagues compared screening costs per relevant target finding of CRC screening for FITs, MSDTs, and N-G MSDTs based on the results of two studies.

The researchers found that per detected advanced neoplasia case or per early detected CRC case, the screening costs were approximately sevenfold to ninefold higher for MSDT- and N-G MSDT-based screening than for FIT-based screening, assuming 60 percent uptake of colonoscopy after a positive fecal test result. Per additional early-detected CRC case, costs were more than $700,000 for both MSDT- and N-G MSDT-based screening compared with FIT-based screening, and these costs were about 40 and 30 times higher, respectively, than costs for the FIT-detected CRC cases. The cost per additional case of CRC or advanced neoplasia detected by MSDT or N-G MSDT compared with FIT would still be manyfold higher even if the costs per test for MSDT and N-G MSDT were lowered to $100 (i.e., less than 20 percent of the current costs).

"Our results indicate that there would be much to gain if the current trends of decreasing FIT use rates and increasing MSDT use rates in the United States could be reversed," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords